Gary E. McVeigh

5.1k total citations · 1 hit paper
80 papers, 4.0k citations indexed

About

Gary E. McVeigh is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gary E. McVeigh has authored 80 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Cardiology and Cardiovascular Medicine, 17 papers in Physiology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gary E. McVeigh's work include Cardiovascular Health and Disease Prevention (34 papers), Blood Pressure and Hypertension Studies (22 papers) and Nitric Oxide and Endothelin Effects (15 papers). Gary E. McVeigh is often cited by papers focused on Cardiovascular Health and Disease Prevention (34 papers), Blood Pressure and Hypertension Studies (22 papers) and Nitric Oxide and Endothelin Effects (15 papers). Gary E. McVeigh collaborates with scholars based in United Kingdom, United States and Bangladesh. Gary E. McVeigh's co-authors include Jay N. Cohn, Stanley M. Finkelstein, Paul Hamilton, G. Brennan, Dennis J. Morgan, Lawrence T. McGrath, J. R. Hayes, B. J. McDermott, GD Johnston and Christopher Lockhart and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Diabetes Care.

In The Last Decade

Gary E. McVeigh

78 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impaired endothelium-dependent and independent vasodilation in patients with Type 2 (non-insulin-dependent) diabetes mellitus

1992 749 citations Gary E. McVeigh, G. Brennan et al. Diabetologia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary E. McVeigh United Kingdom	31	2.4k	873	585	576	523	80	4.0k
Harry A.J. Struijker-Boudier Netherlands	33	2.7k 1.2×	579 0.7×	626 1.1×	566 1.0×	405 0.8×	103	4.3k
Umberto Campia United States	33	1.7k 0.7×	856 1.0×	461 0.8×	679 1.2×	345 0.7×	86	3.6k
Adrian Iaina Israel	37	1.7k 0.7×	1.0k 1.2×	517 0.9×	647 1.1×	470 0.9×	162	6.0k
Kevin C. Dellsperger United States	36	1.7k 0.7×	1.2k 1.4×	644 1.1×	763 1.3×	237 0.5×	108	4.5k
Jeong Bae Park South Korea	32	1.8k 0.8×	613 0.7×	789 1.3×	522 0.9×	330 0.6×	109	3.4k
Marie Gerhard United States	15	2.6k 1.1×	967 1.1×	698 1.2×	758 1.3×	278 0.5×	17	4.4k
H. Thurston United Kingdom	34	3.5k 1.5×	920 1.1×	1.1k 1.9×	847 1.5×	533 1.0×	170	5.2k
Markus P. Schneider Germany	34	2.1k 0.9×	777 0.9×	864 1.5×	1.1k 1.9×	382 0.7×	141	4.4k
Hein A. Koomans Netherlands	46	2.8k 1.2×	1.5k 1.7×	828 1.4×	1.2k 2.1×	432 0.8×	132	6.8k
Yasuaki Dohi Japan	33	2.4k 1.0×	1.7k 1.9×	603 1.0×	483 0.8×	365 0.7×	150	4.2k

Countries citing papers authored by Gary E. McVeigh

Since Specialization

Citations

This map shows the geographic impact of Gary E. McVeigh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary E. McVeigh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary E. McVeigh more than expected).

Fields of papers citing papers by Gary E. McVeigh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary E. McVeigh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary E. McVeigh. The network helps show where Gary E. McVeigh may publish in the future.

Co-authorship network of co-authors of Gary E. McVeigh

This figure shows the co-authorship network connecting the top 25 collaborators of Gary E. McVeigh. A scholar is included among the top collaborators of Gary E. McVeigh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary E. McVeigh. Gary E. McVeigh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bleakley, Caroline, et al.. (2015). Ultrasound entropy may be a new non-invasive measure of pre-clinical vascular damage in young hypertensive patients. Cardiovascular Ultrasound. 13(1). 12–12. 4 indexed citations

Dasgupta, Indranil, et al.. (2013). Management of Hyperphosphataemia in Chronic Kidney Disease: Summary of National Institute for Health and Clinical Excellence (NICE) Guideline. Nephron Clinical Practice. 124(1-2). 1–9. 37 indexed citations

Bleakley, Caroline, et al.. (2012). Lifetime Risk of Cardiovascular Disease: The Next Generation in Risk Prediction. Canadian Journal of Cardiology. 29(2). 147–150. 4 indexed citations

Lockhart, Christopher, et al.. (2010). Effect of pioglitazone on endothelial function in impaired glucose tolerance. Diabetes Obesity and Metabolism. 12(8). 709–715. 16 indexed citations

Wright, Stephen, M. Brent McHenry, William J. Leahey, et al.. (2008). A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus. Lara D. Veeken. 47(2). 25 indexed citations

Morgan, David R., Lana Dixon, Colm G. Hanratty, et al.. (2006). Effects of Dietary Omega-3 Fatty Acid Supplementation on Endothelium-Dependent Vasodilation in Patients With Chronic Heart Failure. The American Journal of Cardiology. 97(4). 547–551. 60 indexed citations

Morgan, David R., Lana Dixon, Colm G. Hanratty, et al.. (2004). Impaired Endothelium-Dependent and -Independent Vasodilation in Elderly Patients with Chronic Heart Failure. European Journal of Heart Failure. 6(7). 901–908. 20 indexed citations

McVeigh, Gary E., et al.. (2004). Vascular abnormalities in hypertension: Cause, effect, or therapeutic target?. Current Hypertension Reports. 6(3). 171–176. 21 indexed citations

McVeigh, Gary E.. (2003). Clinical Hypertension in Practice.. PubMed Central. 72(1). 65–65. 2 indexed citations

10.

Morgan, D. R., Bernard Silke, Lana Dixon, et al.. (2003). Central and peripheral haemodynamic effects of l-NAME infusion in healthy volunteers. European Journal of Clinical Pharmacology. 59(3). 195–199. 4 indexed citations

11.

McGrath, Lawrence T., Lana Dixon, David R. Morgan, & Gary E. McVeigh. (2002). Production of 8-epi prostaglandin F2α in human platelets during administration of organic nitrates. Journal of the American College of Cardiology. 40(4). 820–825. 14 indexed citations

12.

Glasser, Stephen P., Donna K. Arnett, Gary E. McVeigh, et al.. (1998). The Importance of Arterial Compliance in Cardiovascular Drug Therapy. The Journal of Clinical Pharmacology. 38(3). 202–212. 28 indexed citations

13.

McGrath, Lawrence T., et al.. (1996). Effect of dietary fish oil supplementation on peroxidation of serum lipids in patients with non-insulin dependent diabetes mellitus. Atherosclerosis. 121(2). 275–283. 30 indexed citations

14.

McVeigh, Gary E.. (1996). Arterial Compliance in Hypertension and Diabetes mellitus. American Journal of Nephrology. 16(3). 217–222. 20 indexed citations

15.

McDowell, I.F.W., G. Brennan, Jane McEneny, et al.. (1994). The effect of probucol and vitamin E treatment on the oxidation of low‐density lipoprotein and forearm vascular responses in humans. European Journal of Clinical Investigation. 24(11). 759–765. 53 indexed citations

16.

McVeigh, Gary E., et al.. (1994). Primary nitrate tolerance in diabetes mellitus. Diabetologia. 37(1). 115–117. 26 indexed citations

17.

McVeigh, Gary E., et al.. (1993). Hypertension therapy in the elderly.. PubMed. 2(3). 386–94. 2 indexed citations

18.

McVeigh, Gary E., et al.. (1993). Vascular abnormalities in non-insulin-dependent diabetes mellitus identified by arterial waveform analysis. The American Journal of Medicine. 95(4). 424–430. 109 indexed citations

19.

McVeigh, Gary E., Durand E. Burns, Stanley M. Finkelstein, et al.. (1991). Reduced Vascular Compliance as a Marker for Essential Hypertension. American Journal of Hypertension. 4(3 Pt 1). 245–251. 116 indexed citations

20.

McVeigh, Gary E., D. B. Galloway, & Dennis Johnston. (1988). The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide.. BMJ. 297(6641). 95–98. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact